Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CRBPCorbus Pharmaceuticals Holdings, Inc.

Nasdaq · CIK 0001595097
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts372

Identity from submissions API

NameCorbus Pharmaceuticals Holdings, Inc.
CIK0001595097
TickersCRBP
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN464348039
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-963-0103
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • SAV Acquisition Corp (2014-01-10T05:00:00.000Z → 2014-01-10T05:00:00.000Z)
Business address
500 RIVER RIDGE DRIVE
NORWOOD
MA
02062
MA
Mailing address
500 RIVER RIDGE DRIVE
NORWOOD
MA
02062
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

812 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 8-K 8-K 7.01,8.01,9.01 0001193125-26-462186 001-37348 261555586 34 24488419 1 1
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001687078-26-000022 005-88716 261550534 34 6956
2026-11-10 10-Q 10-Q 0001193125-26-455614 001-37348 261541036 34 9289151 1 1
2026-11-10 8-K 8-K 2.02,7.01,9.01 0001193125-26-454476 001-37348 261538056 34 439536 1 1
2026-11-02 4 xslF345X06/form4.xml 0000929638-26-004182 9680
2026-11-02 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000929638-26-004181 005-88716 261512281 34 9041
2026-10-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001716774-26-000025 005-88716 261498569 34 8973
2026-10-15 8-K 8-K 7.01,9.01 0001193125-26-422437 001-37348 261461834 34 26268105 1 1
2026-09-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000243 005-88716 261427780 34 18905
2026-09-15 4 4 0001193125-26-392093 5547
2026-09-14 8-K 8-K 7.01,8.01,9.01 0001193125-26-389829 001-37348 261375788 34 25178230 1 1
2026-08-17 4 4 0001193125-26-354145 8351
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097066 005-88716 261281006 34 17983
2026-08-12 4 4 0001193125-26-346966 4856
2026-08-10 4 4 0001193125-26-342485 5569
2026-08-10 4 4 0001193125-26-342479 5571
2026-08-07 424B5 424B5 0001193125-26-340378 333-277888 261254835 33 735502
2026-08-07 144 xsl144X01/primary_doc.xml 0001972481-26-000255 001-37348 261254369 33 5133
2026-08-07 144 xsl144X01/primary_doc.xml 0001972481-26-000254 001-37348 261253889 33 5114
2026-08-06 10-Q 10-Q 0001193125-26-338274 001-37348 261249824 34 10212115 1 1
2026-08-06 8-K 8-K 2.02,7.01,9.01 0001193125-26-336864 001-37348 261246194 34 432157 1 1
2026-08-04 3 3 0001193125-26-332936 13907
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002244 005-88716 261206129 34 10889
2026-07-27 144 xsl144X01/primary_doc.xml 0001972481-26-000237 001-37348 261205798 33 6623
2026-07-06 8-K 8-K 1.01,7.01,9.01 0001193125-26-295622 001-37348 261154332 34 482299 1 1
2026-06-17 S-8 S-8 0001193125-26-274226 333-296858 261098950 33 742535 1 1
2026-06-11 4 4 0001193125-26-267672 5531
2026-06-11 4 4 0001193125-26-267655 5487
2026-06-11 4 4 0001193125-26-267671 5554
2026-06-03 4 4 0001193125-26-255834 6809
2026-05-29 S-8 S-8 0001193125-26-248550 333-296370 261045582 33 337014 1 1
2026-05-26 8-K 8-K 7.01,8.01,9.01 0001193125-26-238059 001-37348 261016074 34 23570350 1 1
2026-05-22 4 4 0001193125-26-237103 8272
2026-05-22 3 3 0001193125-26-237096 15086
2026-05-21 4 4 0001193125-26-234860 7402
2026-05-21 4 4 0001193125-26-234857 7438
2026-05-21 4 4 0001193125-26-234853 7425
2026-05-21 4 4 0001193125-26-234851 7358
2026-05-21 4 4 0001193125-26-234850 7419
2026-05-21 4 4 0001193125-26-234813 7834
2026-05-21 3 3 0001193125-26-234777 14695
2026-05-21 8-K 8-K 1.01,5.02,7.01,9.01 0001193125-26-233507 001-37348 261005945 34 494571 1 1
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-006202 005-88716 26978576 34 10969
2026-05-14 8-K 8-K 5.02,5.07,7.01,9.01 0001193125-26-222890 001-37348 26975966 34 270349 1 1
2026-05-12 10-Q 10-Q 0001193125-26-219707 001-37348 26969519 34 8140224 1 1
2026-05-12 8-K 8-K 2.02,7.01,9.01 0001193125-26-218250 001-37348 26965981 34 368096 1 1
2026-04-16 DEFA14A DEFA14A 0001193125-26-159074 001-37348 26867872 34 29154
2026-04-16 8-K 8-K 5.02,9.01 0001193125-26-159062 001-37348 26867842 34 743555 1 1
2026-04-14 8-K 8-K 7.01,8.01,9.01 0001193125-26-153923 001-37348 26859233 34 193502 1 1
2026-04-07 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-26-144588 001-37348 26842986 34 199829 1 1
2026-04-02 ARS ARS 0001193125-26-140398 001-37348 26834859 34 5686139
2026-04-02 DEFA14A DEFA14A 0001193125-26-140385 001-37348 26834808 34 2601904
2026-04-02 DEF 14A DEF 14A 0001193125-26-140363 001-37348 26834719 34 5997997 1 1
2026-03-25 424B3 424B3 0001193125-26-124201 333-294217 26792884 33 488258
2026-03-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000891 333-294217 26779753 33 1834
2026-03-18 CORRESP filename1.htm 0001193125-26-113993 19638
2026-03-13 UPLOAD filename1.pdf 0000000000-26-002620 333-294217 40171
2026-03-11 S-3 S-3 0001193125-26-102396 333-294217 26744354 33 2268859 1 1
2026-03-09 10-K 10-K 0001193125-26-098530 001-37348 26735155 34 19801376 1 1
2026-03-09 8-K 8-K 2.02,7.01,9.01 0001193125-26-097582 001-37348 26733209 34 23682090 1 1
2026-03-04 4 4 0001193125-26-091647 5808
2026-03-02 144 xsl144X01/primary_doc.xml 0001972481-26-000071 001-37348 26707610 33 4973
2026-02-25 8-K 8-K 7.01,9.01 0001193125-26-068566 001-37348 26674234 34 22896294 1 1
2026-02-18 4 4 0001193125-26-057174 5791
2026-02-18 4 4 0001193125-26-057168 5879
2026-02-18 4 4 0001193125-26-057159 5878
2026-02-13 144 xsl144X01/primary_doc.xml 0001972481-26-000054 001-37348 26632437 33 4473
2026-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-26-001397 005-88716 26614833 34 10871
2026-02-04 4 4 0001193125-26-037647 5808
2026-02-04 4 4 0001193125-26-037643 5792
2026-01-16 4 4 0001193125-26-015429 8239
2026-01-16 4 4 0001193125-26-015427 8188
2026-01-16 4 4 0001193125-26-015426 8187
2026-01-16 4 4 0001193125-26-015430 8223
2026-01-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001716774-26-000003 005-88716 26537956 34 8743
2026-01-12 8-K 8-K 7.01,9.01 0001193125-26-009758 001-37348 26524663 34 22451187 1 1
2025-12-18 8-K 8-K 5.02 0001193125-25-324796 001-37348 251583059 34 155856 1 1
2025-12-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000929638-25-004599 005-88716 251571859 34 8974
2025-12-15 4 xslF345X05/form4.xml 0000929638-25-004597 9249
2025-12-11 8-K 8-K 7.01,8.01,9.01 0001193125-25-315039 001-37348 251563512 34 21032563 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004964 005-88716 251483989 34 11024
2025-11-12 10-Q 10-Q 0001193125-25-277748 001-37348 251473448 34 9285621 1 1
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-110417 005-88716 251473173 34 26813
2025-11-12 8-K 8-K 2.02,7.01,9.01 0001193125-25-276062 001-37348 251469167 34 428647 1 1
2025-11-03 8-K 8-K 1.01,7.01,9.01 0001193125-25-261722 001-37348 251442173 34 1005701 1 1
2025-11-03 424B5 424B5 0001193125-25-261717 333-277888 251442161 33 976893
2025-10-30 8-K 8-K 8.01 0001193125-25-258692 001-37348 251436263 34 159911 1 1
2025-10-30 424B5 424B5 0001193125-25-258685 333-277888 251436245 33 971185
2025-10-27 4 4 0001193125-25-251639 14774
2025-10-27 4 4 0001193125-25-251635 9296
2025-10-24 144 xsl144X01/primary_doc.xml 0001972481-25-000257 001-37348 251416427 33 4474
2025-10-24 144 xsl144X01/primary_doc.xml 0001972481-25-000256 001-37348 251416361 33 4477
2025-10-21 4 4 0001193125-25-245262 8566
2025-10-20 8-K 8-K 7.01,8.01,9.01 0001193125-25-243046 001-37348 251402341 34 19553209 1 1
2025-09-16 8-K 8-K 7.01,8.01,9.01 0001193125-25-204389 001-37348 251315933 34 187685 1 1
2025-08-05 10-Q 10-Q 0000950170-25-103118 001-37348 251185453 34 8968504 1 1
2025-08-05 8-K 8-K 2.02,7.01,9.01 0000950170-25-102447 001-37348 251183129 34 425041 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000833 005-88716 251159137 34 6302
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002503 005-88716 251128447 34 10846
2025-06-02 4 4 0000950170-25-080313 7266
2025-06-02 4 4 0000950170-25-080311 9356
2025-06-02 4 4 0000950170-25-080312 7176
2025-06-02 4 4 0000950170-25-080310 9293
2025-06-02 4 4 0000950170-25-080309 7244
2025-06-02 4 4 0000950170-25-080308 7270
2025-05-19 8-K 8-K 5.07,8.01 0000950170-25-073967 001-37348 25961577 34 194380 1 1
2025-05-06 10-Q 10-Q 0000950170-25-064507 001-37348 25917583 34 8406661 1 1
2025-05-06 8-K 8-K 2.02,7.01,9.01 0000950170-25-063990 001-37348 25915384 34 377716 1 1
2025-04-01 ARS ARS 0000950170-25-048613 001-37348 25800352 34 5329766
2025-04-01 DEFA14A DEFA14A 0000950170-25-048607 001-37348 25800330 34 245010
2025-04-01 DEF 14A DEF 14A 0000950170-25-048603 001-37348 25800306 34 8416483 1 1
2025-03-21 8-K 8-K 5.02 0000950170-25-043276 001-37348 25761088 34 164692 1 1
2025-03-18 3 3 0000950170-25-041301 22840
2025-03-18 8-K 8-K 5.02,9.01 0000950170-25-041254 001-37348 25748860 34 559561 1 1
2025-03-11 10-K 10-K 0000950170-25-037335 001-37348 25728858 34 19214933 1 1
2025-03-11 8-K 8-K 2.02,7.01,9.01 0000950170-25-036838 001-37348 25725949 34 434101 1 1
2025-03-07 4 4 0000950170-25-035547 5817
2025-03-06 144 xsl144X01/primary_doc.xml 0001972481-25-000048 001-37348 25715140 33 4388
2025-02-18 4 4 0000950170-25-022514 5836
2025-02-18 4 4 0000950170-25-022512 5883
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000947871-25-000162 005-88716 25629581 34 15809
2025-02-14 144 xsl144X01/primary_doc.xml 0001972481-25-000032 001-37348 25629137 33 4431
2025-02-14 144 xsl144X01/primary_doc.xml 0001972481-25-000031 001-37348 25629047 33 4477
2025-02-14 8-K 8-K 7.01,8.01,9.01 0000950170-25-020424 001-37348 25623340 34 23234616 1 1
2025-02-04 4 4 0000950170-25-013704 8248
2025-02-04 4 4 0000950170-25-013702 8145
2025-02-04 4 4 0000950170-25-013697 8195
2024-12-03 8-K 8-K 7.01,8.01,9.01 0000950170-24-132458 001-37348 241521174 34 189344 1 1
2024-11-15 8-K 8-K 8.01 0000950170-24-127644 001-37348 241468442 34 159898 1 1
2024-11-14 SC 13G/A CORBUS PHARMACEUTICALS HOLDINGS, INC. 0000902664-24-006642 005-88716 241465286 34 56407
2024-11-14 SC 13G SCHEDULE 13G 0000947871-24-000914 005-88716 241465059 34 68772
2024-11-14 SC 13G/A SC 13G/A 0001140361-24-046892 005-88716 241461896 34 117313
2024-11-14 SC 13G/A AMENDMENT NO. 1 0001214659-24-019105 005-88716 241461366 34 81642
2024-11-14 SC 13G/A cormorant-crbp093024a2.htm 0001172661-24-005058 005-88716 241460791 34 86526
2024-11-12 SC 13G/A UnitedStates_13G__CorbusPhar.txt 0000932471-24-000998 005-88716 241447047 34 6631
2024-11-12 SC 13G/A CORBUS PHARMACEUTICALS HOLDINGS, INC. 0000902664-24-006420 005-88716 241444282 34 72172
2024-11-08 SC 13G us21833p3010_110824.txt 0002012383-24-003579 005-88716 241439740 34 13775
2024-11-07 10-Q 10-Q 0000950170-24-123486 001-37348 241436859 34 8166031 1 1
2024-11-07 8-K 8-K 2.02,7.01,9.01 0000950170-24-122839 001-37348 241433387 34 26461488 1 1
2024-11-04 SC 13G/A UnitedStates_13G__CorbusPhar.txt 0000932471-24-000364 005-88716 241421525 34 5680
2024-11-04 8-K 8-K 7.01,8.01,9.01 0000950170-24-120289 001-37348 241420778 34 26274604 1 1
2024-10-22 SC 13G us21833p3010_102224.txt 0002012383-24-001592 005-88716 241387292 34 13765
2024-10-15 SC 13G/A CRBP_SC13GA1.htm 0001273087-24-000100 005-88716 241372049 34 81806
2024-10-11 SC 13G crbp1011241sc13g.htm 0001214659-24-017478 005-88716 241367542 34 68831
2024-09-24 4 xslF345X05/form4.xml 0000929638-24-003217 19438
2024-09-04 144 xsl144X01/primary_doc.xml 0001972481-24-000218 001-37348 241278127 33 4307
2024-09-03 8-K 8-K 8.01 0000950170-24-102878 001-37348 241274781 34 159887 1 1
2024-08-20 4 4 0000950170-24-099175 7315
2024-08-20 3 3 0000950170-24-099169 12587
2024-08-20 8-K 8-K 5.02,7.01,9.01 0000950170-24-098861 001-37348 241222772 34 202982 1 1
2024-08-06 8-K 8-K 7.01,9.01 0000950170-24-091931 001-37348 241180041 34 33698346 1 1
2024-08-06 10-Q 10-Q 0000950170-24-091922 001-37348 241179989 34 8214343 1 1
2024-08-06 8-K 8-K 2.02,7.01,9.01 0000950170-24-091219 001-37348 241177195 34 388609 1 1
2024-06-18 4 4 0000950170-24-075075 26006
2024-06-18 4 4 0000950170-24-075071 42623
2024-06-17 8-K 8-K 8.01 0000950170-24-074032 001-37348 241047117 34 148868 1 1
2024-06-14 144 xsl144X01/primary_doc.xml 0001972481-24-000152 001-37348 241046091 33 5448
2024-06-14 144 xsl144X01/primary_doc.xml 0001972481-24-000151 001-37348 241046085 33 6022
2024-06-14 4 4 0000950170-24-073710 16445
2024-06-03 4 4 0000950170-24-068039 14504
2024-06-03 4 4 0000950170-24-068035 14435
2024-06-03 4 4 0000950170-24-068030 14269
2024-06-03 4 4 0000950170-24-068014 14341
2024-06-03 4 4 0000950170-24-068013 14236
2024-06-03 4 4 0000950170-24-068009 14487
2024-06-03 4 4 0000950170-24-068005 14260
2024-06-03 8-K 8-K 7.01,8.01,9.01 0000950170-24-067651 001-37348 241011969 34 32427850 1 1
2024-05-31 S-8 S-8 0000950170-24-067373 333-279883 241010385 33 443497
2024-05-20 4 FORM 4 SUBMISSION 0001209191-24-005676 5535
2024-05-20 4 FORM 4 SUBMISSION 0001209191-24-005675 5594
2024-05-20 4 FORM 4 SUBMISSION 0001209191-24-005674 5566
2024-05-20 4 FORM 4 SUBMISSION 0001209191-24-005673 5579
2024-05-20 4 FORM 4 SUBMISSION 0001209191-24-005672 5525
2024-05-20 4 FORM 4 SUBMISSION 0001209191-24-005671 5467
2024-05-20 4 FORM 4 SUBMISSION 0001209191-24-005670 5487
2024-05-20 8-K 8-K 5.02,5.07,9.01 0000950170-24-062436 001-37348 24965028 34 760531 1 1
2024-05-09 8-K 8-K 8.01 0000950170-24-056291 001-37348 24928660 34 192951 1 1
2024-05-08 144 xsl144X01/primary_doc.xml 0001972481-24-000108 001-37348 24925775 33 5374
2024-05-07 10-Q 10-Q 0000950170-24-054625 001-37348 24922615 34 7914297 1 1
2024-05-07 8-K 8-K 2.02,7.01,9.01 0000950170-24-053978 001-37348 24919771 34 337531 1 1
2024-04-11 4 FORM 4 SUBMISSION 0001209191-24-005284 7962
2024-04-10 DEFA14A DEFA14A 0000950170-24-043418 001-37348 24836474 34 42294
2024-04-10 8-K 8-K 5.02,9.01 0000950170-24-043417 001-37348 24836466 34 650923 1 1
2024-04-02 ARS ARS 0000950170-24-040250 001-37348 24814931 34 2287293
2024-04-02 DEFA14A DEFA14A 0000950170-24-040247 001-37348 24814889 34 171148
2024-04-02 DEF 14A DEF 14A 0000950170-24-040242 001-37348 24814853 34 2429480 1 1
2024-03-22 PRE 14A PRE 14A 0000950170-24-035466 001-37348 24776108 34 1368431
2024-03-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-03-20 16:15:00 9999999995-24-000696 333-277888 24769286 33 1841
2024-03-20 8-K 8-K 8.01 0000950170-24-034271 001-37348 24768562 34 148672 1 1
2024-03-20 10-K/A 10-K/A 0000950170-24-034266 001-37348 24768533 34 3022030 1 1
2024-03-20 424B3 424B3 0000950170-24-034262 333-277888 24768513 33 245480
2024-03-18 SC 13G/A AMENDMENT NO. 1 0000929638-24-001033 005-88716 24759136 34 98492
2024-03-18 CORRESP filename1.htm 0000950170-24-032536 16319
2024-03-15 UPLOAD filename1.pdf 0000000000-24-002905 333-277888 40428
2024-03-13 S-3 S-3 0000950170-24-030848 333-277888 24746701 33 2068350
2024-03-12 10-K 10-K 0000950170-24-030133 001-37348 24743408 34 13451345 1 1
2024-03-12 8-K 8-K 2.02,7.01,9.01 0000950170-24-029667 001-37348 24740272 34 341472 1 1
2024-03-11 4 xslF345X05/form4.xml 0000929638-24-000985 27651
2024-02-29 4 FORM 4 SUBMISSION 0001209191-24-004120 11468
2024-02-29 3 FORM 3 SUBMISSION 0001209191-24-004119 6237
2024-02-28 SC 13G CRBP_SC13G_2024.htm 0001273087-24-000053 005-88716 24696175 34 81901
2024-02-14 SC 13G/A SC 13G/A 0001140361-24-008026 005-88716 24639629 34 122863
2024-02-14 SC 13G SC 13G 0001140361-24-008023 005-88716 24639533 34 116434
2024-02-14 SC 13G SC 13G 0001104659-24-023629 005-88716 24637996 34 68127
2024-02-14 4 FORM 4 SUBMISSION 0001209191-24-003337 8350
2024-02-14 4 FORM 4 SUBMISSION 0001209191-24-003336 8396
2024-02-12 SC 13G CORBUS PHARMACEUTICALS HOLDINGS, INC. 0000902664-24-001435 005-88716 24620710 34 100581
2024-02-12 SC 13G SC 13G 0001104659-24-014646 005-88716 24620199 34 87197
2024-02-09 SC 13G CRBP_SC13G.htm 0001319244-24-000026 005-88716 24614987 34 96408
2024-02-06 8-K 8-K 5.02 0000950170-24-011733 001-37348 24600397 34 146527 1 1
2024-02-06 4 xslF345X05/form4.xml 0000929638-24-000383 8550
2024-02-05 SC 13G sch13g.htm 0000929638-24-000374 005-88716 24596458 34 110807
2024-02-05 SC 13G SC 13G 0001104659-24-010623 005-88716 24596003 34 64605
2024-02-05 8-K 8-K 7.01,9.01 0000950170-24-011013 001-37348 24594010 34 29064373 1 1
2024-02-02 8-K/A 8-K/A 9.01 0000950170-24-009973 001-37348 24588576 34 187679 1 1
2024-02-01 8-K 8-K 1.01,7.01,9.01 0000950170-24-009874 001-37348 24588016 34 668887 1 1
2024-02-01 424B5 424B5 0000950170-24-009865 333-272314 24587844 33 850329
2024-01-31 S-3MEF S-3MEF 0000950170-24-009164 333-276776 24580819 33 188606
2024-01-31 8-K 8-K 8.01 0000950170-24-009086 001-37348 24580328 34 147913 1 1
2024-01-31 424B5 424B5 0000950170-24-009084 333-272314 24580327 33 847736
2024-01-30 4 FORM 4 SUBMISSION 0001209191-24-002449 7190
2024-01-30 4 FORM 4 SUBMISSION 0001209191-24-002419 6957
2024-01-30 4 xslF345X05/form4.xml 0000929638-24-000304 35860
2024-01-30 3 xslF345X02/form3.xml 0000929638-24-000303 7906
2024-01-29 SC 13G CORBUS PHARMACEUTICALS HOLDINGS, INC. 0000902664-24-000754 005-88716 24574229 34 70644
2024-01-29 8-K 8-K 8.01 0000950170-24-008129 001-37348 24570104 34 150014 1 1
2024-01-29 424B3 424B3 0000950170-24-008127 333-272314 24570097 33 25851
2024-01-26 SC 13G g126243sc13g.htm 0001214659-24-001240 005-88716 24568297 34 84970
2024-01-26 8-K 8-K 7.01,8.01,9.01 0000950170-24-007703 001-37348 24564221 34 28703361 1 1
2024-01-09 8-K 8-K 3.01,7.01,8.01,9.01 0000950170-24-003197 001-37348 24521811 34 189711 1 1
2023-11-14 8-K 8-K 7.01,9.01 0000950170-23-063854 001-37348 231408011 34 25382187 1 1
2023-11-13 8-K 8-K 3.01,8.01 0000950170-23-063134 001-37348 231400182 34 171347 1 1
2023-11-07 10-Q 10-Q 0000950170-23-060377 001-37348 231384884 34 10119899 1 1
2023-11-07 8-K 8-K 2.02,7.01,9.01 0000950170-23-059812 001-37348 231382083 34 487197 1 1
2023-08-08 10-Q 10-Q 0000950170-23-039960 001-37348 231152599 34 10865668 1 1
2023-08-08 8-K 8-K 2.02,7.01,9.01 0000950170-23-039409 001-37348 231149558 34 526210 1 1
2023-08-03 8-K 8-K 8.01,9.01 0000950170-23-037620 001-37348 231138269 34 21375153 1 1
2023-06-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-06-13 16:15:00 9999999995-23-001739 333-272314 231012884 33 1793
2023-06-13 424B3 424B3 0000950170-23-027746 333-272314 231011993 33 334300
2023-06-12 S-3/A S-3/A 0001193125-23-165391 333-272314 231008816 33 395597
2023-06-07 CORRESP filename1.htm 0000950170-23-026822 23349
2023-06-07 UPLOAD filename1.pdf 0000000000-23-006053 40296
2023-06-01 S-3 S-3 0001193125-23-158143 333-272314 23982805 33 1225799
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031474 5404
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031471 5510
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031467 5482
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031460 5451
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031453 5495
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031448 5383
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031441 5441
2023-05-19 8-K 8-K 5.07 0000950170-23-023162 001-37348 23938007 34 217223 1 1
2023-05-09 10-Q 10-Q 0000950170-23-019825 001-37348 23903122 34 9793740 1 1
2023-05-09 8-K 8-K 2.02,7.01,9.01 0000950170-23-019170 001-37348 23900124 34 440588 1 1
2023-04-24 8-K/A 8-K/A 5.02,9.01 0000950170-23-014119 001-37348 23840594 34 289786 1 1
2023-04-03 DEF 14A DEF 14A 0000950170-23-011611 001-37348 23793193 34 2331463 1 1
2023-04-03 ARS ARS 0000950170-23-011609 001-37348 23793188 34 4055614
2023-04-03 DEFA14A DEFA14A 0000950170-23-011610 001-37348 23793186 34 184622
2023-03-10 S-8 S-8 0000950170-23-007308 333-270468 23724153 33 291597
2023-03-07 10-K 10-K 0000950170-23-006469 001-37348 23712990 34 17943828 1 1
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016575 5383
2023-03-07 3 FORM 3 SUBMISSION 0001209191-23-016574 2867
2023-03-07 8-K 8-K 2.02,5.02,7.01,8.01,9.01 0000950170-23-006385 001-37348 23711165 34 19874008 1 1
2023-03-06 8-K 8-K 5.02,7.01,9.01 0000950170-23-006132 001-37348 23707735 34 207104 1 1
2023-02-15 4 FORM 4 SUBMISSION 0001209191-23-009635 5525
2023-02-15 4 FORM 4 SUBMISSION 0001209191-23-009634 5577
2023-02-15 4 FORM 4 SUBMISSION 0001209191-23-009633 5551
2023-02-15 4 FORM 4 SUBMISSION 0001209191-23-009631 5600
2023-02-15 8-K/A 8-K/A 3.03 0000950170-23-002815 001-37348 23632482 34 173046 1 1
2023-02-13 8-K 8-K 1.01,5.03,7.01,8.01,9.01 0000950170-23-002534 001-37348 23614790 34 18404222 1 1
2023-01-06 8-K 8-K 3.01,8.01 0000950170-23-000351 001-37348 23515717 34 179987 1 1
2022-12-21 8-K 8-K 5.07 0000950170-22-026875 001-37348 221478886 34 183819 1 1
2022-12-21 8-K 8-K 2.02,7.01,9.01 0000950170-22-026872 001-37348 221478830 34 543309 1 1
2022-11-14 DEF 14A DEF 14A 0000950170-22-025075 001-37348 221387865 34 418382
2022-11-08 10-Q 10-Q 0000950170-22-023282 001-37348 221369468 34 10425389 1 1
2022-11-04 PRE 14A PRE 14A 0000950170-22-022213 001-37348 221362870 34 409168
2022-10-31 8-K 8-K 1.01,9.01 0000950170-22-020636 001-37348 221347311 34 267387 1 1
2022-10-12 8-A12G 8-A12G 0000950170-22-019507 000-55327 221307380 34 89501
2022-10-12 8-K 8-K 3.03,5.03,9.01 0000950170-22-019502 001-37348 221307209 34 277765 1 1
2022-09-28 4 FORM 4 SUBMISSION 0001209191-22-051425 5411
2022-09-28 3 FORM 3 SUBMISSION 0001209191-22-051423 2887
2022-09-26 8-K 8-K 5.02,7.01,9.01 0000950170-22-018857 001-37348 221266470 34 200457 1 1
2022-08-24 SC 13G/A AMENDMENT NO. 18 TO SCHEDULE 13G 0001213900-22-050731 005-88716 221190916 34 43209
2022-08-12 4 FORM 4 SUBMISSION 0001209191-22-045524 4606
2022-08-11 4 FORM 4 SUBMISSION 0001209191-22-045358 4625
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045137 4582
2022-08-09 10-Q 10-Q 0000950170-22-016150 001-37348 221149271 34 9756053 1 1
2022-08-09 8-K 8-K 2.02,7.01,9.01 0000950170-22-015864 001-37348 221147212 34 539855 1 1
2022-07-07 8-K 8-K 3.01,8.01 0000950170-22-012529 001-37348 221072301 34 169449 1 1
2022-06-08 8-K 8-K 8.01,9.01 0000950170-22-011301 001-37348 221002640 34 2638846 1 1
2022-05-23 8-K 8-K 5.07 0000950170-22-010506 001-37348 22952589 34 203855 1 1
2022-05-19 4 FORM 4 SUBMISSION 0001209191-22-030447 5485
2022-05-19 4 FORM 4 SUBMISSION 0001209191-22-030446 5498
2022-05-19 4 FORM 4 SUBMISSION 0001209191-22-030445 5513
2022-05-19 4 FORM 4 SUBMISSION 0001209191-22-030444 5454
2022-05-19 4 FORM 4 SUBMISSION 0001209191-22-030437 5444
2022-05-17 8-K 8-K 8.01 0000950170-22-010202 001-37348 22935559 34 164772 1 1
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029031 4579
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029030 4624
2022-05-10 10-Q 10-Q 0000950170-22-009050 001-37348 22910824 34 9447505 1 1
2022-05-10 8-K 8-K 2.02,7.01,9.01 0000950170-22-008743 001-37348 22907492 34 442741 1 1
2022-04-15 8-K 8-K 5.02,9.01 0000950170-22-005730 001-37348 22830327 34 1047588 1 1
2022-04-11 8-K 8-K 7.01,8.01,9.01 0000950170-22-005547 001-37348 22818645 34 8660730 1 1
2022-04-01 DEFA14A DEFA14A 0000950170-22-005264 001-37348 22795870 34 550154
2022-04-01 DEF 14A DEF 14A 0000950170-22-005263 001-37348 22795845 34 1384996
2022-03-15 S-8 S-8 0001193125-22-076252 333-263583 22742051 33 72327
2022-03-11 4 FORM 4 SUBMISSION 0001209191-22-018101 4604
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017781 4579
2022-03-09 4 FORM 4 SUBMISSION 0001209191-22-017449 4623
2022-03-08 10-K 10-K 0000950170-22-003145 001-37348 22722577 34 12153653 1 1
2022-03-08 8-K 8-K 2.02,7.01,9.01 0000950170-22-003066 001-37348 22720384 34 452748 1 1
2022-02-14 SC 13G/A AMENDMENT NO. 17 TO SCHEDULE 13G 0001213900-22-007461 005-88716 22630960 34 48212
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006519 5575
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006515 5598
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006511 5520
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006505 5550
2022-01-03 8-K 8-K 3.01 0000950170-22-000021 001-37348 22502833 34 166101 1 1
2021-12-08 4 FORM 4 SUBMISSION 0001209191-21-068508 5556
2021-12-08 3 FORM 3 SUBMISSION 0001209191-21-068503 6041
2021-11-12 10-Q 10-Q 0000950170-21-004269 001-37348 211399924 34 9363899 1 1
2021-11-12 8-K 8-K 2.02,7.01,9.01 0000950170-21-004261 001-37348 211399829 34 497817 1 1
2021-09-28 8-K form8-k.htm 5.02,9.01 0001493152-21-023935 001-37348 211284010 34 237710 1 1
2021-09-22 8-K/A form8-ka.htm 5.02,9.01 0001493152-21-023317 001-37348 211268191 34 291806 1 1
2021-08-18 8-K form8-k.htm 5.02 0001493152-21-020508 001-37348 211185046 34 206902 1 1
2021-08-12 10-Q form10-q.htm 0001493152-21-019441 001-37348 211165618 34 10244586 1 1
2021-08-12 8-K form8-k.htm 2.02,7.01,9.01 0001493152-21-019439 001-37348 211165591 34 291073 1 1
2021-07-22 8-K form8-k.htm 8.01,9.01 0001493152-21-017498 001-37348 211106121 34 19824549 1 1
2021-06-24 8-K form8-k.htm 7.01,8.01,9.01 0001493152-21-015154 001-37348 211040717 34 400654 1 1
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041467 7863
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041462 7922
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041461 7894
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041459 7907
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041455 7853
2021-06-17 8-K form8-k.htm 5.03,5.07,9.01 0001493152-21-014663 001-37348 211025150 34 550278 1 1
2021-06-01 SC 13G/A AMENDMENT NO.16 TO SCHEDULE 13G 0001213900-21-030186 005-88716 21984314 34 47538
2021-06-01 8-K form8-k.htm 1.01,3.02,7.01,8.01,9.01 0001493152-21-013297 001-37348 21982982 34 13936960 1 1
2021-05-19 DEFA14A defa14a.htm 0001493152-21-012193 001-37348 21938562 34 33366
2021-05-13 10-Q form10-q.htm 0001493152-21-011221 001-37348 21917527 34 5756940 1 1
2021-05-13 8-K form8-k.htm 2.02,7.01,9.01 0001493152-21-011211 001-37348 21917323 34 282916 1 1
2021-05-11 SC 13G/A AMENDMENT NO.15 TO SCHEDULE 13G 0001213900-21-025576 005-88716 21910611 34 47670
2021-04-12 SC 13G/A us21833p1030_040921.txt 0000834237-21-008113 005-88716 21818843 34 12322
2021-04-06 DEFA14A formdef14a.htm 0001493152-21-008111 001-37348 21809697 34 750722
2021-04-06 DEF 14A formdef14a.htm 0001493152-21-008107 001-37348 21809685 34 1034782
2021-03-26 PRE 14A formpre14a.htm 0001493152-21-006927 001-37348 21778047 34 1036033
2021-03-17 SC 13G/A AMENDMENT NO. 14 TO SCHEDULE 13G 0001213900-21-016035 005-88716 21749838 34 39248
2021-03-16 S-8 forms-8.htm 0001493152-21-006121 333-254350 21746421 33 104105
2021-03-15 10-K form10-k.htm 0001493152-21-006016 001-37348 21742621 34 7041517 1 1
2021-03-15 8-K form8-k.htm 2.02,5.03,7.01,9.01 0001493152-21-005952 001-37348 21739865 34 312421 1 1
2021-02-16 SC 13G/A AMENDMENT NO. 13 TO SCHEDULE 13G 0001213900-21-009356 005-88716 21634156 34 40990
2021-02-12 SC 13G/A AMENDMENT NO. 12 TO SCHEDULE 13G 0001213900-21-008829 005-88716 21625159 34 40971
2021-02-04 4 FORM 4 SUBMISSION 0001209191-21-007742 8021
2021-02-04 4 FORM 4 SUBMISSION 0001209191-21-007741 8100
2021-02-04 4 FORM 4 SUBMISSION 0001209191-21-007736 8081
2021-02-04 4 FORM 4 SUBMISSION 0001209191-21-007727 8105
2021-02-04 8-K form8-k.htm 5.02 0001493152-21-002634 001-37348 21591132 34 211692 1 1
2021-01-29 SC 13G/A us21833p1030_012821.txt 0000834237-21-002988 005-88716 21566918 34 13208
2021-01-27 8-K form8-k.htm 8.01,9.01 0001493152-21-001868 001-37348 21556798 34 5051307 1 1
2021-01-11 SC 13G/A CorbusPharmaceuticals.txt 0000093751-21-000006 005-88716 21519661 34 8421
2021-01-08 SC 13G/A AMENDMENT NO. 11 TO SCHEDULE 13G 0001213900-21-001112 005-88716 21516670 34 49757
2020-12-22 4 FORM 4 SUBMISSION 0001209191-20-064849 14068
2020-12-18 4 FORM 4 SUBMISSION 0001209191-20-064437 9310
2020-12-11 SC 13G/A AMENDMENT NO. 10 TO SCHEDULE 13G 0001213900-20-042180 005-88716 201382864 34 46522
2020-12-04 8-K/A form8-ka.htm 5.02,9.01 0001493152-20-022963 001-37348 201370123 34 261361 1 1
2020-11-16 SC 13G/A AMENDMENT NO. 9 TO SCHEDULE 13G 0001213900-20-037197 005-88716 201314828 34 56443
2020-11-16 8-K form8k.htm 7.01,9.01 0001493152-20-021434 001-37348 201313815 34 6935919 1 1
2020-11-12 4 FORM 4 SUBMISSION 0001209191-20-057851 4625
2020-11-10 8-K form8-k.htm 2.02,7.01,8.01,9.01 0001493152-20-020885 001-37348 201299820 34 7368234 1 1
2020-11-09 10-Q form10-q.htm 0001493152-20-020841 001-37348 201298614 34 5296343 1 1
2020-11-06 SC 13G/A AMENDMENT NO. 8 TO SCHEDULE 13G 0001213900-20-035462 005-88716 201292859 34 50489
2020-10-13 SC 13G/A CPHInc.txt 0000093751-20-000967 005-88716 201236114 34 10392
2020-10-08 8-K form8-k.htm 2.05,5.02,7.01,8.01,9.01 0001493152-20-019126 001-37348 201230284 34 250280 1 1
2020-10-06 8-K form8-k.htm 7.01,8.01,9.01 0001493152-20-018978 001-37348 201225626 34 240999 1 1
2020-09-25 8-K form8-k.htm 5.02 0001493152-20-018325 001-37348 201196871 34 206607 1 1
2020-09-15 8-K form8-k.htm 5.02 0001493152-20-017794 001-37348 201174787 34 207211 1 1
2020-09-08 8-K form8-k.htm 7.01,8.01,9.01 0001493152-20-017365 001-37348 201163045 34 274209 1 1
2020-08-31 10-Q/A form10-qa.htm 0001493152-20-017022 001-37348 201152688 34 5132891 1 1
2020-08-07 SC 13G/A AMENDMENT NO. 7 TO SCHEDULE 13G 0001213900-20-020809 005-88716 201084448 34 44770
2020-08-07 424B5 form424b5.htm 0001493152-20-014904 333-222447 201083410 33 1180030
2020-08-07 424B5 form424b5.htm 0001493152-20-014902 333-237588 201083400 33 1180030
2020-08-06 10-Q form10-q.htm 0001493152-20-014895 001-37348 201082902 34 3958799 1
2020-08-06 8-K form8-k.htm 2.02,7.01,9.01 0001493152-20-014810 001-37348 201079843 34 202262
2020-07-29 8-K form8-k.htm 1.01,2.03,3.02,7.01,9.01 0001493152-20-014133 001-37348 201055839 34 1100179
2020-07-08 4 xslF345X03/ownership.xml 0001493152-20-012802 5466
2020-07-08 3 xslF345X02/ownership.xml 0001493152-20-012801 11840
2020-07-08 8-K form8-k.htm 5.02,7.01,9.01 0001493152-20-012800 001-37348 201017305 34 83978
2020-05-22 4 FORM 4 SUBMISSION 0001209191-20-031663 5411
2020-05-22 4 FORM 4 SUBMISSION 0001209191-20-031662 5511
2020-05-22 4 FORM 4 SUBMISSION 0001209191-20-031661 5493
2020-05-22 4 FORM 4 SUBMISSION 0001209191-20-031660 5546
2020-05-22 4 FORM 4 SUBMISSION 0001209191-20-031659 5444
2020-05-22 4 FORM 4 SUBMISSION 0001209191-20-031658 5454
2020-05-21 8-K form8-k.htm 5.07 0001493152-20-009623 001-37348 20901882 34 44624
2020-05-11 10-Q form10-q.htm 0001493152-20-008248 001-37348 20865226 34 3923658 1
2020-05-11 8-K form8-k.htm 2.02,7.01,9.01 0001493152-20-008150 001-37348 20862641 34 172528
2020-05-04 424B3 form424b3.htm 0001493152-20-007596 333-237588 20842875 33 216141
2020-05-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-05-01 16:15:00 9999999995-20-001005 333-237588 20842605 33 1792
2020-04-30 CORRESP filename1.htm 0001493152-20-007445 13854
2020-04-24 CORRESP filename1.htm 0001493152-20-007096 24860
2020-04-24 S-3/A forms-3a.htm 0001493152-20-007094 333-237588 20816252 33 746020
2020-04-24 SC 13G/A AMENDMENT NO. 6 TO SCHEDULE 13G 0001213900-20-010018 005-88716 20813200 34 41466
2020-04-21 8-K/A form8-ka.htm 5.02,9.01 0001493152-20-006836 001-37348 20805175 34 36262

Latest XBRL company facts

One latest value per concept from companyfacts (372 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 20.61M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
dei EntityPublicFloat Entity Public Float USD 67.80M 2025-06-30 2025 FY 10-K 2026-03-09 0001193125-26-098530
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 1 2014-08-01 2014-08-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 200,000 2015-06-30 2015 Q2 10-Q 2015-08-13 0001193125-15-289161
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 30.17M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1,500 2016-06-30 2016 Q2 10-Q 2016-08-12 0001493152-16-012283
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 109,442 2016-06-30 2016 Q2 10-Q 2016-08-12 0001493152-16-012283
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 4.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -196,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 736.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 148.89M 2018-12-31 2018 FY 10-K 2019-03-12 0001493152-19-003143
us-gaap AdjustmentForAmortization Amortization USD 1.25M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-10 0001564590-15-010364
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 5.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 11,512 2018-07-01 2018-09-30 2019 Q3 10-Q 2019-11-07 0001493152-19-016601
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 807,149 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-08 0000950170-22-003145
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.80M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006016
us-gaap AreaOfLand Area of Land sqft 6,326 2015-12-31 2016 FY 10-K 2017-03-08 0001493152-17-002256
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap Assets Assets USD 122.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AssetsCurrent Assets, Current USD 118.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019825
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 85.29M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039960
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039960
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 81.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 81.11M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 85.09M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 376,664 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006016
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 11,638 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-12 0001493152-18-003208
us-gaap Cash Cash USD 3.89M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 30.25M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 6.57M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001493152-16-014751
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 30.63M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 30.63M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 8.26M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001493152-18-006568
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 1.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 26.35M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 6.34 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2,873 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 2.28M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 20.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 20.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 330,413 2016-12-31 2017 FY 10-K 2018-03-12 0001493152-18-003208
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -95.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 393,172 2019-06-30 2019 Q2 10-Q 2019-08-08 0001493152-19-011835
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 1.62M 2020-12-31 2021 FY 10-K 2022-03-08 0000950170-22-003145
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 2.48M 2019-06-30 2019 Q2 10-Q 2019-08-08 0001493152-19-011835
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -3.94M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006016
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-10 0001564590-15-010364
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 1.13M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 573,002 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.033 2014-10-31 2015 Q3 10-Q 2015-11-10 0001564590-15-010364
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 24,293 2014-10-01 2014-10-31 2015 Q3 10-Q 2015-11-10 0001564590-15-010364
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 35,996 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 1.38M 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap DeferredRevenue Deferred Revenue USD 1.94M 2016-12-31 2017 FY 10-K 2018-03-12 0001493152-18-003208
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 270,530 2020-06-30 2020 Q2 10-Q/A 2020-08-31 0001493152-20-017022
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 260,260 2015-12-31 2016 FY 10-K 2017-03-08 0001493152-17-002256
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 2.89M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 127.61M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 78.53M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 19.66M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 1.43M 2017-12-31 2018 FY 10-K 2019-03-12 0001493152-19-003143
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 887,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 13.33M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 13.50M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 7.24M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 409,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 127.61M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap Depreciation Depreciation USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 0 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091922
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.18 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016150
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.161 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.011 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.023 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.018 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0.009 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent pure 0.056 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.66M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 5.40M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent EntertainmentLicenseAgreementForProgramMaterialLiabilityNoncurrent USD 775,000 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-10 0001564590-15-010364
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 6.22M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001493152-21-011221
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2014-01-01 2014-06-30 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.66 2014-01-01 2014-06-30 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.013 2014-01-01 2014-06-30 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 823,615 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 279,585 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 252,333 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 291,697 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 252,333 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 291,697 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 196,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123486
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 45,833 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 35,209 2015-09-30 2015 Q3 10-Q 2015-11-10 0001564590-15-010364
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactions Future Minimum Sublease Rentals, Sale Leaseback Transactions USD 1.11M 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingAfterYearFive Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling after Year Five USD 252,333 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearFive Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Five USD 290,688 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearFour Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Four USD 278,576 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearThree Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Three USD 185,717 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearTwo Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Two USD 104,971 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactionsNextRollingTwelveMonths Future Minimum Sublease Rentals, Sale Leaseback Transactions, Next Rolling Twelve Months USD 0 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD 39,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123486
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -790 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD -606,078 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 145,006 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 14.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 1.00M 2016-12-31 2017 FY 10-K 2018-03-12 0001493152-18-003208
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 1.50M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277748
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1,877 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-08 0001493152-17-012574
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 12.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -16.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 587,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 21.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 124,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -2.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 13.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD -212,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091922
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -3.98M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001493152-19-011835
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -4.73M 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019441
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 10,205 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-08 0001493152-17-012574
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 1.47M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 7,905 2016-01-01 2016-03-31 2017 Q1 10-Q 2017-05-09 0001493152-17-004896
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.88M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001493152-18-003208
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 1.38M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 599,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -5.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 150,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001493152-16-014751
us-gaap InterestExpense Interest Expense USD 1.49M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091922
us-gaap InterestExpenseDebt Interest Expense, Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap InterestExpenseLesseeAssetsUnderCapitalLease Interest Expense, Lessee, Assets under Capital Lease USD 712 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001493152-18-003208
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 2.76M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123486
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 1.08M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001493152-19-016601
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2,562 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001493152-17-008712
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 232,844 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023282
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 114,642 2020-01-01 2020-06-30 2020 Q2 10-Q/A 2020-08-31 0001493152-20-017022
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 761,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 587,963 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001493152-19-003143
us-gaap LeaseCost Lease, Cost USD 1.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 19,310 2015-09-30 2015 Q3 10-Q 2015-11-10 0001564590-15-010364
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 309,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 953,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 653,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.28M 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019825
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.35M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 13,728 2014-07-01 2016 FY 10-K 2017-03-08 0001493152-17-002256
us-gaap Liabilities Liabilities USD 38.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 122.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 195,181 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-12 0001493152-21-019441
us-gaap LiabilitiesCurrent Liabilities, Current USD 34.97M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap LineOfCreditFacilityIncreaseDecreaseForPeriodNet Line of Credit Facility, Increase (Decrease), Net USD 36,375 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-12 0001493152-16-012283
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap LoansPayable Loans Payable USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap LongTermDebt Long-term Debt USD 17.89M 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 12.76M 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054625
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 14.56M 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054625
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 8.26M 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006016
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 8.26M 2021-12-31 2021 FY 10-K 2022-03-08 0000950170-22-003145
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 17.89M 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039960
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 2.13M 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054625
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2016-03-31 2016 Q1 10-Q 2016-05-13 0001564590-16-019363
us-gaap MarketableSecurities Marketable Securities USD 0 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006016
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 69.74M 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -143,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 63.23M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001493152-21-011221
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 27.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 11.13M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001493152-18-006568
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 50.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -1.27M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001493152-18-006568
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -76.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -1.60M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001493152-18-006568
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -95.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -78.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -12.43M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001493152-16-014751
us-gaap NetInvestmentIncome Net Investment Income USD 3.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap NotesPayable Notes Payable USD 271,757 2016-12-31 2017 Q3 10-Q 2017-11-08 0001493152-17-012574
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-06 0001493152-20-014895
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OperatingExpenses Operating Expenses USD 99.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -99.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.70M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 732,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 724,858 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 5.03M 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 623,958 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 879,699 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 855,150 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 830,600 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 784,243 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.06M 2018-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 117,500 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 969,370 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001493152-17-004896
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 99.75M 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 4.57M 2020-12-31 2021 Q2 10-Q 2021-08-12 0001493152-21-019441
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.74M 2021-12-31 2021 FY 10-K 2022-03-08 0000950170-22-003145
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 0 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091922
us-gaap OtherAssets Other Assets USD 2.21M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -143,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -8,967 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -143,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OtherIncome Other Income USD -100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap OtherLongTermDebtCurrent Other Long-term Debt, Current USD 12.76M 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054625
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 4.58M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -86,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 3.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.50M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 29,861 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 6.69M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054625
us-gaap PaymentsForRent Payments for Rent USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 6.86M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054625
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 63.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 77.27M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PreferredUnitsOfferingCosts Preferred Units, Offering Costs USD 1.86M 2014-12-31 2014 FY 10-K 2015-02-10 0001193125-15-040326
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 3.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.09M 2021-12-31 2022 Q2 10-Q 2022-08-09 0000950170-22-016150
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PrepaidRent Prepaid Rent USD 250,000 2021-08-26 2024 Q1 10-Q 2024-05-07 0000950170-24-054625
us-gaap PrepaidTaxes Prepaid Taxes USD 1.50M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-10 0001193125-15-040326
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 109.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 27.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 18.76M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 1.38M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 8.40M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 100 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 80,248 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001493152-17-004896
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037335
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 7.02M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 113.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 909,375 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006016
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 337,645 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.12M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -95.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 34,482 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001493152-17-002256
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 36,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap ReceivablesFromCustomers Receivables from Customers USD 5.00M 2020-06-30 2020 Q2 10-Q/A 2020-08-31 0001493152-20-017022
us-gaap RepaymentsOfDebt Repayments of Debt USD 1.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 375 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006016
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 752,659 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001493152-20-020841
us-gaap RepaymentsOfOtherLongTermDebt Repayments of Other Long-term Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 85.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap RestrictedCash Restricted Cash USD 385,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 158,991 2017-12-31 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 158,991 2017-12-31 2018 FY 10-K 2019-03-12 0001493152-19-003143
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 50,000 2016-12-31 2017 FY 10-K 2018-03-12 0001493152-18-003208
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 385,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -651.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 12.50M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap Revenues Revenues USD 1.89M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001493152-19-006611
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 3.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 13,165 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 4.44 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 31,076 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.84 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 17,911 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 5.14 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 5.67M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001493152-18-015417
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 86,719 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 19.81M 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 838,540 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.83 2019-12-31 2019 FY 10-K 2020-03-16 0001493152-20-004077
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 26.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 191,886 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.2 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 498,543 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 29,019 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 43.06 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 29.59 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 203,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.17M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 26.52 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 401,416 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060377
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 52.13 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 17.88M 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 663,007 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 67.78 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-030133
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 3.60M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001493152-20-020841
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 107,269 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 67.54 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006469
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 9.79 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 9.59 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap ShortTermInvestments Short-term Investments USD 85.09M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 84.76M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 5.86M 2014-12-31 2014 FY 10-K 2015-02-10 0001193125-15-040326
us-gaap StockIssued1 Stock Issued USD 225,501 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-12 0001493152-19-003143
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 947,454 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001493152-19-006611
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 812 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 396,192 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 1.11M 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 27.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 5,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001493152-19-003143
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.15M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-28 0001564590-16-015403
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap SubleaseIncome Sublease Income USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004269
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 1.76M 2020-12-31 2021 Q2 10-Q 2021-08-12 0001493152-21-019441
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 22.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098530
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 3.96M 2019-04-01 2019-06-30 2020 Q2 10-Q/A 2020-08-31 0001493152-20-017022
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 19.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 125.25M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016150
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 19.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455614

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →